Recommended Prophylaxis Regimen for Spontaneous Bacterial Peritonitis (SBP)
Norfloxacin 400 mg once daily is the first-choice prophylactic regimen for SBP prevention in high-risk patients with cirrhosis and ascites. 1
Indications for SBP Prophylaxis
SBP prophylaxis should be initiated in the following scenarios:
Secondary Prophylaxis:
Primary Prophylaxis:
- Patients with low ascitic fluid protein (<1.5 g/dL) AND at least one of:
- Child-Pugh score ≥9 with serum bilirubin >3 mg/dL
- Impaired renal function
- Serum sodium <130 mEq/L 1
- High serum bilirubin (>3.2 mg/dL) and low platelet count (<98,000/mm³) are independent risk factors for developing first SBP episode 2
- Patients with low ascitic fluid protein (<1.5 g/dL) AND at least one of:
Gastrointestinal Bleeding:
- All cirrhotic patients with ascites and acute GI hemorrhage should receive short-term prophylaxis for 7 days 1
Recommended Prophylactic Regimens
First-Line Options:
- Norfloxacin 400 mg once daily (first choice) 1
- Reduces SBP recurrence from 68% to 20%
- Particularly effective against gram-negative bacteria
Alternative Options:
- Ciprofloxacin 500 mg once daily (primary alternative) 1
- Weekly ciprofloxacin 750 mg has also shown efficacy in reducing SBP incidence (3.6% vs 22% with placebo) 3
- Trimethoprim-sulfamethoxazole 800/160 mg daily (alternative option) 1
- Rifaximin (emerging evidence suggests possibly superior efficacy) 1
For Acute GI Bleeding:
- IV ceftriaxone for 7 days OR
- Norfloxacin 400 mg twice daily for 7 days 1
Monitoring During Prophylaxis
- Check renal function every 1-3 months 1
- Perform periodic cultures to detect resistant organisms 1
- Monitor for fluoroquinolone side effects:
- Rare but serious musculoskeletal complications
- Nervous system side effects 1
- Monitor for trimethoprim-sulfamethoxazole adverse events:
- Rash
- Hyperkalemia
- Bone marrow suppression 1
Important Considerations and Pitfalls
Underutilization: Despite clear guidelines, only one-third of patients who survive SBP receive appropriate long-term prophylaxis after discharge 1
Antibiotic Resistance: Long-term prophylaxis has led to increasing gram-positive and multi-drug resistant organisms 1
- Consider alternative antibiotics if infection develops with resistant bacteria
- Quinolone prophylaxis is less effective in patients colonized with multi-drug resistant organisms
Mortality Benefit: Meta-analyses demonstrate that fluoroquinolone prophylaxis reduces not only SBP incidence but also mortality in high-risk patients 4
Albumin Consideration: For active SBP treatment (not prophylaxis), human albumin administration in addition to antibiotics decreases hepatorenal syndrome frequency and improves survival 1
The evidence strongly supports that the benefits of prophylaxis in appropriate candidates outweigh the risks of long-term antibiotic use, with significant reductions in infection rates and mortality 1, 4.